Campus Charitè Mitte Charité Centrum 10. Klinik f.Urologie

Berlin 10117

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Transitional Cell

Studies at this site

• A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection — Stopped early